Neo Ivy Capital Management

Position in ABBV — AbbVie Inc.

CIK 1727783 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$881,243

+$480,472 QoQ

Shares Held

3,502

+99.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#2,665

of 4,153 holders

Holding Since

Mar 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Neo Ivy Capital Management holds $8,085,964 across 5 Drug Manufacturers - General names. ABBV ranks #3 (10.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	144,562	$3,481,052
2	BMY	Bristol Myers Squibb Co	54,404	$3,134,758
3	ABBV	AbbVie Inc. This page	3,502	$881,243
4	MRK	Merck & Co., Inc.	3,119	$400,791
5	GILD	Gilead Sciences, Inc.	1,489	$188,120

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$881,243	3,502	+99.7%	Shares	Sole	2026-08-14
2025-12-31	$400,771	1,754	+95.8%	Shares	Sole	2026-02-13
2025-03-31	$187,729	896	+0.2%	Shares	Sole	2025-05-06
2023-06-30	$120,448	894	-23.9%	Shares	Sole	2023-08-16
2022-09-30	$157,562	1,174	+115.0%	Shares	Sole	2022-11-16
2022-03-31	$88,512	546	-75.4%	Shares	Sole	2022-05-16
2021-06-30	$250,286	2,222	-40.0%	Shares	Sole	2021-08-16
2021-03-31	$400,630	3,702	-18.0%	Shares	Sole	2021-10-07
2020-09-30	$395,381	4,514	+38.8%	Shares	Sole	2020-11-17
2020-03-31	$247,846	3,253	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.